These cells are defined as a CD14+HLA-DRlo population and it was observed that an increased frequency of this cell subset is associated with poor prognosis, higher leukemic burden and decreased time to progression in CLL patients [20]. This evidence concerns the gene CD14 and B-cell chronic lymphocytic leukemia.